Clinical trial
Observational Study in Neonatal Intensive Care Units (NICU) on the Real Life Use of Curosurf in Prophylaxis of RDS in Premature Babies.
NCT01102543 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study in Neonatal Intensive Care Units (NICU) on the Real Life Use of Curosurf in Prophylaxis of RDS in Premature Babies.
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- March 31, 2011
- Enrollment
- 972 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.